BicMag Study - Improving Mineral Buffering Capacity in Dialysis Patients
ConditionEnd Stage Renal Disease
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorElisabethinen Hospital
About this trial
The BicMag study is a prospective, randomized, controlled cross-over study that aims to examine the potential additive effect of a dialysate enriched with both bicarbonate and magnesium on mineral buffering capacity in the blood of chronic hemodialysis patients.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Prevalent patients (≥ 3 months) treated with thrice weekly hemodialysis or hemodiafiltration
Dialysate calcium of 1.25 mmol/l
Disqualifiers
Inability to provide informed consent
Currently participating in another investigational device or drug study or non-interventional study
Dialysate calcium other than 1.25 mmol/l
Parathyroidectomy planned during the study
Trial design
Treatments tested in this trial
- D-Standard
- D-Bic
- D-Mag
- D-BicMag
Treatment groups
91 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov